Yahoo Web Search

Search results

1. • 

     Earnings call: Verona Pharma reports Q1 2024 results, eyes COPD market By Investing.com

     Investing.com· 2 days ago

     Verona Pharma (NASDAQ:VRNA) has announced its first quarter 2024 financial results, highlighting the...

2. • Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - Verona...

     Benzinga· 2 days ago

     PDUFA Target Action Date for Ensifentrine of June 26, 2024 Finalizing commercial launch preparations Strong balance sheet supports commercialization and pipeline expansion Conference call today at 9:00 a.m. EDT /

3. • 

     Insmed Incorporated (NASDAQ:INSM) Q1 2024 Earnings Call Transcript

     Insider Monkey via Yahoo Finance· 17 hours ago

     Insmed Incorporated (NASDAQ:INSM) Q1 2024 Earnings Call Transcript May 9, 2024 Insmed Incorporated...

4. • 

     Varenicline Leads in Helping Smokers Kick the Habit, Study

     Medscape· 2 days ago

     Most smokers do successfully quit after their first attempt. Switching patients from nicotine...

5. • Theravance Biopharma to Participate in an Upcoming Investor Conference

     WKRN Nashville· 2 days ago

     Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a Fireside Chat at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ Monday, May 20 at 11:30 AM EDT (8:30 ...

6. • 

     Smoking on oxygen killed 3 York countians this year. A $4.45 device might have saved them

     Hanover Evening Sun via Yahoo News· 4 days ago

     "Typically, but not all the time, people who are on supplemental oxygen have a respiratory problem,...

7. • Viemed Healthcare (VMD) to Release Earnings on Tuesday

     ETF DAILY NEWS· 5 days ago

     Viemed Healthcare (NASDAQ:VMD – Get Free Report) is scheduled to announce its earnings results before the market opens on Tuesday, May 7th. Viemed Healthcare has set its Q1 2024 guidance at ...

8. • ASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of...

     Benzinga· 4 days ago

     ASLAN Pharmaceuticals ASLN, a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, will today ...

9. • The Interplay: Key Decisions at the Intersection of Antitrust & Life Sciences - April 2024 | JD...

     JD Supra· 4 days ago

     This week, the FTC continued its intense regulatory focus on pharmaceutical patents listed in the FDA’s Orange Book. As reported in earlier editions of The Interplay, the FTC issued a policy ...

10. • 

      Pulmonary hypertension: Dietary changes may help with treatment, study finds

      MedicalNewsToday via AOL· 3 days ago

      Researchers say dietary changes that limit the amino acids glutamine and serine may help slow...